menu
    • menu

    Company profile for Biolexis Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biolexis Therapeutics is a privately held clinical-stage biopharmaceutical company committed to the development of small molecules targeting a diverse range of diseases. These diseases include cancers, immune-mediated conditions, neurodegenerative disorders, auto-immune diseases, metabolic disorders, and inflammatory diseases. Biolexis employs a rapid and accurate drug discovery process facilitated by its proprietary MolecuLer...
    Biolexis Therapeutics is a privately held clinical-stage biopharmaceutical company committed to the development of small molecules targeting a diverse range of diseases. These diseases include cancers, immune-mediated conditions, neurodegenerative disorders, auto-immune diseases, metabolic disorders, and inflammatory diseases. Biolexis employs a rapid and accurate drug discovery process facilitated by its proprietary MolecuLern AI-enabled platform. This platform enhances the speed and precision of discovering and developing novel clinical candidates, allowing Biolexis to advance innovative solutions for a broad spectrum of medical conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biolexis TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    858 S Auto Mall Dr. #102 American Fork, UT 84003
    Telephone
    Telephone
    +1 8016923655
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biolexistx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biolexis-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biolexis Therapeutics Advances GLP-1 and AMPK Programs into Trial
    Biolexis Therapeutics Advances GLP-1 and AMPK Programs into Trial

    12 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolexis-therapeutics-advances-breakthrough-glp-1-and-ampk-programs-into-first-in-human-clinical-trials-302479986.html

    PR NEWSWIRE
    12 Jun 2025
    Share Share
    Biolexis Reports Positive DIO Model Results for BLX-7006
    Biolexis Reports Positive DIO Model Results for BLX-7006

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolexis-therapeutics-announces-positive-results-from-expanded-diet-induced-obesity-dio-model-study-for-blx-7006-302325341.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share
    Biolexis Completes Studies On Isoform-Specific Ampk Agonists
    Biolexis Completes Studies On Isoform-Specific Ampk Agonists

    29 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolexis-therapeutics-completes-promising-pre-clinical-studies-on-novel-isoform-specific-ampk-agonists-for-weight-loss-treatment-302289219.html

    PR NEWSWIRE
    29 Oct 2024
    Share Share
    Biolexis Unveils Promising Preclinical Data For Oral Weight Loss Drug BLX-7006
    Biolexis Unveils Promising Preclinical Data For Oral Weight Loss Drug BLX-7006

    12 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolexis-unveils-promising-data-with-an-oral-weight-loss-drug-blx-7006-shows-significant-results-in-preclinical-studies-302245673.html

    PR NEWSWIRE
    12 Sep 2024
    Share Share
    Halia And Biolexis Identify Candidate For NLRP3-Driven Neuroinflammation
    Halia And Biolexis Identify Candidate For NLRP3-Driven Neuroinflammation

    31 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halia-therapeutics-and-biolexis-therapeutics-partnership-successfully-identifies-novel-clinical-candidate-targeting-nlrp3-driven-neuroinflammation-302210473.html

    PR NEWSWIRE
    31 Jul 2024
    Share Share
    Biolexis to Present Two Groundbreaking Abstracts at Scientific Conference
    Biolexis to Present Two Groundbreaking Abstracts at Scientific Conference

    21 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolexis-therapeutics-to-present-two-groundbreaking-abstracts-at-upcoming-scientific-conference-302178449.html

    PR NEWSWIRE
    21 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search